RE: Easier NHS treatment4 May 2026 10:25
Offering both benefit to patients and savings to the NHS whilst extending patent protection with a divisional filing for when the original patent expires in 2029. Win, win, win. A clear demonstration of how big pharma are keen to find patent extending modifications to known warheads.